Financials CSPC Pharmaceutical Group Limited

Equities

1093

HK1093012172

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 03:08:09 2026-02-13 am EST			5-day change	1st Jan Change
10.11 ^HKD	-0.30%		+4.66%	+19.93%

Feb. 11	China charges former AstraZeneca regional head Leon Wang	RE
Feb. 03	Asian Stock Markets Rally on Renewed AI Fervor; Tokyo, Seoul Strike Zeniths Again	MT

Projected Income Statement: CSPC Pharmaceutical Group Limited

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	29,762	34,309	35,292	34,175	31,046	31,011	34,206	35,225
Change	-	15.28%	2.87%	-3.17%	-9.15%	-0.11%	10.3%	2.98%
EBITDA ¹	8,192	9,431	9,148	8,615	7,547	7,649	9,854	9,002
Change	-	15.13%	-3.01%	-5.83%	-12.4%	1.36%	28.82%	-8.64%
EBIT ¹	7,227	8,366	7,952	7,400	6,113	6,564	8,444	8,104
Change	-	15.76%	-4.95%	-6.94%	-17.4%	7.38%	28.63%	-4.02%
Interest Paid ¹	-14.61	-9.423	-28.39	-28.14	-46.77	-48.22	-50.53	-50.68
Earnings before Tax (EBT) ¹	7,626	8,430	8,650	8,030	5,971	6,954	9,341	8,404
Change	-	10.54%	2.61%	-7.17%	-25.64%	16.47%	34.34%	-10.03%
Net income ¹	6,157	6,901	6,949	6,382	4,632	5,530	7,264	6,656
Change	-	12.09%	0.69%	-8.16%	-27.42%	19.39%	31.35%	-8.36%
Announcement Date	3/15/21	3/22/22	3/22/23	3/20/24	3/28/25	-	-	-

¹HKD in Million

Estimates

Fiscal Period: December	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	6,834	8,126	8,522	8,328	8,895	-	8,883	8,634	8,489	8,938	8,626	8,522	8,242	9,690	7,974	6,887	6,767	7,644	6,810	7,248	8,528	8,119	13,012	8,788	10,693
Change	-	18.91%	4.88%	-2.29%	6.82%	-	-	-2.8%	-1.68%	5.29%	-3.49%	-1.2%	-3.29%	17.57%	-17.71%	-13.63%	-1.74%	12.96%	-10.91%	6.42%	17.66%	-4.79%	60.25%	-32.46%	21.67%
EBITDA ¹	-	-	-	2,330	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,302	1,487	7,855	1,573	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-35.4%	428.3%	-79.97%	-
EBIT ¹	2,277	2,161	1,651	2,074	2,380	-	1,871	1,830	1,928	2,000	2,051	1,865	1,517	2,258	1,946	1,060	911.9	1,953	1,156	1,338	1,957	2,023	5,269	2,254	3,439
Change	-	-5.11%	-23.61%	25.63%	14.79%	-	-	-2.22%	5.38%	3.72%	2.54%	-9.08%	-18.63%	48.8%	-13.8%	-45.55%	-13.94%	114.2%	-40.81%	15.74%	46.29%	3.32%	160.5%	-57.23%	52.61%
Charge d'intérêts	-4.955	-	-	-	-1.498	-	-	-	-	-	-6.762	-	-	-	-	-12.22	-11.12	-7.352	-16.26	-11.15	-	-	-	-	-
Earnings before Tax (EBT) ¹	2,311	-	-	-	-	-	-	-	2,265	1,977	2,139	2,111	1,934	1,921	2,206	1,016	891.7	1,960	1,438	1,298	2,076	2,918	3,045	3,299	3,426
Change	-	-	-	-	-	-	-	-	-	-12.72%	8.22%	-1.31%	-8.39%	-0.65%	14.83%	-53.95%	-12.23%	119.74%	-26.61%	-9.76%	59.95%	40.59%	4.35%	8.33%	3.85%
Net income ¹	1,959	-	-	1,554	1,563	1,657	1,793	1,644	1,852	1,586	1,653	1,672	1,498	1,740	1,537	815.1	588.6	1,612	1,164	1,055	1,635	2,258	2,356	2,553	2,651
Change	-	-	-	-	0.6%	5.98%	8.22%	-8.31%	12.65%	-14.38%	4.23%	1.19%	-10.42%	16.14%	-11.65%	-46.97%	-27.78%	173.95%	-27.8%	-9.35%	54.98%	38.07%	4.35%	8.33%	3.85%
Announcement Date	3/15/21	5/24/21	8/26/21	11/18/21	3/22/22	5/25/22	8/24/22	11/23/22	3/22/23	5/25/23	8/23/23	11/30/23	3/20/24	5/27/24	8/21/24	11/15/24	3/28/25	5/29/25	8/22/25	11/20/25	-	-	-	-	-

¹HKD in Million

Estimates

Fiscal Period: December	2022 S2	2025 S1
Net sales ¹	17,479	14,443
Change	-	-17.37%
EBITDA	-	-
Change	-	-
EBIT ¹	3,697	2,804
Change	-	-24.17%
Charge d'intérêts ¹	-	-23.61
Earnings before Tax (EBT) ¹	4,379	3,392
Change	-	-22.54%
Net income ¹	3,543	2,772
Change	-	-21.75%
Announcement Date	3/22/23	8/22/25

¹HKD in Million

Estimates

Forecast Balance Sheet: CSPC Pharmaceutical Group Limited

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-8,554	-11,298	-11,467	-13,738	-8,238	-10,660	-14,519	-16,984
Change	-	-32.08%	-1.5%	-19.8%	40.03%	-29.4%	-36.2%	-16.98%
Announcement Date	3/15/21	3/22/22	3/22/23	3/20/24	3/28/25	-	-	-

¹HKD in Million

Estimates

Cash Flow Forecast: CSPC Pharmaceutical Group Limited

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	1,613	1,914	2,517	1,754	2,145	2,248	2,302	2,346
Change	-	18.66%	31.47%	-30.29%	22.26%	4.78%	2.42%	1.93%
Free Cash Flow (FCF) ¹	6,404	3,787	6,129	2,761	2,682	5,778	6,867	6,908
Change	-	-40.87%	61.85%	-54.95%	-2.87%	115.48%	18.83%	0.6%
Announcement Date	3/15/21	3/22/22	3/22/23	3/20/24	3/28/25	-	-	-

¹HKD in Million

Estimates

Forecast Financial Ratios: CSPC Pharmaceutical Group Limited

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	27.53%	27.49%	25.92%	25.21%	24.31%	24.67%	28.81%	25.56%
EBIT Margin (%)	24.28%	24.38%	22.53%	21.65%	19.69%	21.17%	24.68%	23.01%
EBT Margin (%)	25.62%	24.57%	24.51%	23.5%	19.23%	22.42%	27.31%	23.86%
Net margin (%)	20.69%	20.11%	19.69%	18.68%	14.92%	17.83%	21.24%	18.9%
FCF margin (%)	21.52%	11.04%	17.37%	8.08%	8.64%	18.63%	20.07%	19.61%
FCF / Net Income (%)	104.01%	54.87%	88.2%	43.26%	57.89%	104.49%	94.53%	103.77%
Profitability
ROA	18.3%	17.3%	15.96%	13.34%	9.55%	10.72%	12.5%	11.72%
ROE	25.3%	23.2%	21.73%	18.53%	13.22%	14.36%	16.27%	14.86%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	5.42%	5.58%	7.13%	5.13%	6.91%	7.25%	6.73%	6.66%
CAPEX / EBITDA (%)	19.69%	20.3%	27.51%	20.37%	28.42%	29.38%	23.36%	26.07%
CAPEX / FCF (%)	25.19%	50.55%	41.06%	63.55%	79.99%	38.9%	33.53%	33.97%
Items per share
Cash flow per share ¹	0.6706	0.4769	0.7254	0.3804	0.4112	0.9185	0.6367	0.7512
Change	-	-28.87%	52.09%	-47.56%	8.1%	123.39%	-30.68%	17.99%
Dividend per Share ¹	0.1275	0.18	0.21	0.28	0.26	0.2935	0.3549	0.3247
Change	-	41.18%	16.67%	33.33%	-7.14%	12.9%	20.91%	-8.51%
Book Value Per Share ¹	2.232	2.673	2.872	3.039	2.944	3.325	3.745	4.079
Change	-	19.77%	7.46%	5.82%	-3.14%	12.94%	12.64%	8.92%
EPS ¹	0.515	0.5773	0.5831	0.5376	0.3946	0.4833	0.6369	0.5761
Change	-	12.09%	1%	-7.8%	-26.6%	22.49%	31.78%	-9.55%
Nbr of stocks (in thousands)	11,954,570	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	11,433,025
Announcement Date	3/15/21	3/22/22	3/22/23	3/20/24	3/28/25	-	-	-